MedTrace Logo

Safety and Effectiveness Evaluation of Two Kinds of Peritoneal Dialysate

NCT01779557 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 750

Last updated 2022-03-10

No results posted yet for this study

Summary

This study is to evaluate the effectiveness and safety of Huaren Peritoneal Dialysate and Baxter Peritoneal Dialysate, investigate the proper dialysis dose for Chinese CAPD patients.

Conditions

  • Kidney Failure,Chronic

Interventions

DRUG

Huaren Peritoneal Dialysate

Huaren Peritoneal dialysate CAPD 3-5 times/d

DRUG

Baxter Peritoneal Dialysate

Baxter Peritoneal dialysate CAPD 3-5 times/d

Sponsors & Collaborators

  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • CHEN Xiangmei, yes · Chinese PLA General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2019-10-31
Completion
2021-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01779557 on ClinicalTrials.gov